| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | 0.13 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.5 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.5 |